DSIP 60mg — Vial Spec, Reconstitution Math & COA

DSIP 60mg Specification & High-Yield Laboratory Utility

Delta-Sleep-Inducing Peptide (DSIP) is an amphiphilic nonapeptide (sequence: Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu; molecular weight: 848.81 g/mol) originally isolated from the cerebral venous blood of rabbit models subjected to electrical stimulation of the thalamus. In preclinical research environments, a 60mg vial configuration represents a high-yield, high-mass lyophilized cake tailored specifically for extended longitudinal rodent studies, automated high-throughput receptor binding assays, or multi-sample microdialysis preparations.

While routine single-assay protocols frequently utilize smaller formats such as the standard analytical DSIP 5mg vial, large-scale institutional projects benefit from the reduced per-milligram unit handling requirements of high-mass 60mg vials. PX1 Research supplies high-purity research compounds manufactured under strict quality standards. Laboratories seeking custom bulk fill configurations, high-mass production runs, or batch-dedicated orders can coordinate directly through our institutional wholesale lab accounts portal, while standard analytical units are available directly within our comprehensive catalog of all peptides.

Molecular Structure, Primary Mechanisms, and Preclinical Literature

In preclinical model systems, DSIP has been extensively evaluated for its distinct modulation of central nervous system rhythms and neuroendocrine axes. Primary literature indicates that DSIP freely crosses the blood-brain barrier via passive diffusion and specific transport mechanisms. Once inside central tissue, the nonapeptide demonstrates a unique biphasic effect on electroencephalographic (EEG) sleep architecture, specifically inducing high-voltage slow-wave activity corresponding to non-REM delta-wave sleep in animal models without suppressing REM sleep phases.

Beyond central EEG modulation, in vitro and in vivo studies indicate that DSIP plays a significant role in stress-axis modulation and physiological recovery during periods of metabolic or environmental stress. Preclinical data suggest that DSIP downregulates basal and stress-induced hypothalamic-pituitary-adrenal (HPA) axis activity by modulating adrenocorticotropic hormone (ACTH) release and corticosterone secretion. Furthermore, research demonstrates that DSIP interacts with central NMDA receptor complexes and antioxidant enzyme pathways—including superoxide dismutase (SOD)—thereby mitigating oxidative damage during induced hypoxia or physiological restraint models. Researchers exploring these pathways can review detailed literature overviews in our central research hub.

Reconstitution Mathematics for 60mg DSIP Vials

Reconstituting a 60mg lyophilized cake requires accurate volumetric calculation to yield working solutions suitable for precise micropipetting and dosing in preclinical assays. Because 60mg is a substantially larger mass than standard analytical vials, solvent selection and final concentration planning are critical to prevent concentration saturation or osmotic shock during in vitro assays.

When reconstituting a 60mg DSIP vial using standard diluents such as Bacteriostatic Water (0.9% benzyl alcohol) or Sterile Normal Saline (0.9% NaCl), the resulting concentration ($C$) is calculated using the formula $C = \text{Mass (mg)} / \text{Volume (mL)}$. The working concentration profiles for common reconstitution volumes are as follows:

1.0 mL Diluent Addition: Yields a final concentration of 60.0 mg/mL (60.0 µg/µL). This hyper-concentrated stock solution is ideal for high-density master mix formulations or micro-injection pump reservoir loading where minimal fluid volume is required.

2.0 mL Diluent Addition: Yields a final concentration of 30.0 mg/mL (30.0 µg/µL). This balanced concentration provides excellent pipette accuracy for medium-scale in vitro cell culture treatments or multi-animal cohort administration.

3.0 mL Diluent Addition: Yields a final concentration of 20.0 mg/mL (20.0 µg/µL). This concentration minimizes pipetting error margins during delicate quantitative assays requiring lower concentration working solutions.

To quickly verify custom dilution ratios, volumetric adjustments, or working stock target concentrations, researchers should utilize our interactive online reconstitution calculator.

Aliquot Planning and Freezing Protocols for High-Mass Vials

Because repetitive freeze-thaw cycles induce thermal shear stress and accelerate peptide bond cleavage—particularly at the N-terminal Tryptophan (Trp1) residue of DSIP—reconstituting a 60mg vial requires an immediate, pre-planned aliquot strategy prior to storage.

Following total dissolution of the lyophilized powder, the primary stock solution should be divided immediately into single-use microcentrifuge tubes (polypropylene or low-protein-binding micro-tubes) under aseptic laminar flow conditions. Aliquot volumes should be calculated to match the exact requirements of a single experimental batch (e.g., 50 µL to 100 µL per sub-vial). Once sub-aliquoted, working stocks must be flash-frozen and stored at -20°C for short-term evaluation (up to 30 days) or -80°C for long-term storage (up to 12 months). Unused reconstituted aliquots should never be re-frozen once thawed.

Analytical Verification & Lot-Matched Certificates of Analysis (COA)

To guarantee experimental reproducibility and baseline purity, every production batch of DSIP supplied by PX1 Research undergoes rigorous chemical and analytical verification. Each lot is subjected to dual-stage analysis using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to establish chromatographic purity and Electrospray Ionization Mass Spectrometry (ESI-MS) to verify precise molecular identity.

Our strict analytical threshold mandates a minimum chromatographic purity of ≥98.0%, with total individual impurities maintained below 0.5%. In addition to identity and purity verification, high-mass formats undergo kinetic chromogenic Limulus Amebocyte Lysate (LAL) testing to confirm that bacterial endotoxin levels remain strictly below <0.05 EU/mg, preventing confounding inflammatory responses in sensitive cellular or animal models. Researchers can independently access, download, and verify lot-specific documentation anytime directly from our public COA database.

Comparative Analysis: DSIP vs. Related Preclinical Research Peptides

When designing preclinical protocols targeted at circadian rhythm regulation, neuroprotection, or physiological recovery, investigators frequently compare DSIP against other major neuroendocrine and regulatory research compounds. Understanding the mechanistic distinctions between these classes allows for refined model selection.

Unlike pineal peptide bioregulators like Epitalon—which primary literature suggests acts principally via telomerase activation, chromatin remodeling, and restoration of endogenous melatonin synthesis rhythmicity—DSIP exerts a direct, acute modulating effect on central sleep architecture and acute HPA-axis activation. Similarly, growth hormone-releasing factor analogs such as Sermorelin and CJC-1295 influence recovery pathways primarily by activating pituitary somatotropes to release growth hormone in a pulsatile manner. While somatotropic secretagogues enhance tissue repair via systemic IGF-1 elevation, DSIP functions via central neurochemical pathways, reducing central stress signaling while directly inducing delta-wave electroencephalographic patterns in research models.

Storage, Lyophilized Matrix Stability, and Handling Protocols

Proper preservation of lyophilized DSIP is critical to maintain structural integrity prior to reconstitution. Lyophilized 60mg vials must be stored in a controlled, dark environment at -20°C upon receipt. Protect the vial from direct light exposure, as photo-oxidation can cause degradation of the N-terminal tryptophan residue.

Prior to reconstitution, allow the sealed vial to equilibrate to room temperature (20°C–25°C) inside a desiccator or sealed container for approximately 30 minutes. Reconstituting a cold vial directly can introduce atmospheric moisture condensation into the matrix, accelerating hydrolysis. When introducing diluent, direct the fluid stream against the glass inner wall rather than directly onto the lyophilized cake. Gently swirl the vial in a circular motion until completely dissolved; high-speed vortexing or violent agitation must be avoided to prevent protein shearing and foam formation.

Selecting the Optimal Format: 5mg Analytical Standard vs. 60mg High-Throughput

Selecting the appropriate vial mass depends on study scale, lab budget, and assay frequency. Purchasing a 60mg bulk vial is mathematically cost-effective and structurally advantageous for large-scale institutional projects, long-term animal cohort studies, or automated robotic liquid handling workstations requiring unified batch consistency.

Conversely, for short-term pilot studies, single-dose in vitro assays, or exploratory benchwork, smaller mass units such as the standard analytical DSIP 5mg format are recommended. Utilizing smaller single-use vials reduces the duration that reconstituted solutions remain in storage, minimizing the risk of degradation or accidental contamination over extended experimental timelines. Laboratories evaluating their operational requirements can inspect complete analytical specifications across all standard catalog items via our all peptides directory.